Updated
ArtivionAORT · Healthcare
$20.21-20.21%
Market cap$986M
IndustryMedical Devices

Artivion (AORT) Superinvestor holders

13 of the superinvestors we track hold Artivion (AORT) in their latest 13F filings, $95M in total.

Summary

The largest holder is Conestoga (Conestoga Capital Advisors), with $31M, 0.9% of the portfolio.

In their latest quarter: 4 opened a new position, 3 added, 5 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Conestoga
Conestoga Capital Advisors
Trimmed 1,369,855$31M 0.9%Q3 2026
Chuck Royce
Royce Investment Partners
Added 889,702$20M 0.2%Q3 2026
Alger
Fred Alger Management
Trimmed 463,111$10M 0.0%Q2 2026
David Shaw
D. E. Shaw & Co.
Added 438,216$10M 0.0%Q2 2026
Two Sigma
Two Sigma Investments
Trimmed 387,279$9M 0.0%Q2 2026
Jean-Marie Eveillard
First Eagle Investment Management
Added 346,573$8M 0.0%Q2 2026
David Vogel
Voloridge Investment Management
Trimmed 127,159$3M 0.0%Q2 2026
Jim Simons
Renaissance Technologies
New position 67,827$2M 0.0%Q2 2026
Eddie Brown
Brown Capital Management
New position 51,908$1M 0.2%Q3 2026
Alan Howard
Brevan Howard
New position 29,037$652,461 0.0%Q2 2026
Cliff Asness
AQR Capital Management
Trimmed 14,383$323,186 0.0%Q2 2026
Ensign Peak
Ensign Peak Advisors
Held 4,569$102,665 0.0%Q2 2026
Acadian
Acadian Asset Management
New position 1,576$35,000 0.0%Q3 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 202611
Q1 202616
Q4 202514
Q3 202513
Q2 202512
Q1 202512
Q4 20249
Q3 20249

Questions about Artivion

Which superinvestors own Artivion?

13 of the superinvestors we track hold Artivion (AORT) in their latest 13F filings, $95M in total. Conestoga, Chuck Royce, Alger, David Shaw, Two Sigma, Jean-Marie Eveillard.

Who is the largest superinvestor holder of AORT?

The largest holder is Conestoga (Conestoga Capital Advisors), with $31M, 0.9% of the portfolio.

From Artivion's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Artivion and thousands of other companies, in one place. Free to start.